December 23, 2003; 61 (12) Articles
Profile of cognitive progression in early Huntington’s disease
A.K. Ho, B.J. Sahakian, R.G. Brown, R.A. Barker, J.R. Hodges, M.-N. Ané, J. Snowden, J. Thompson, T. Esmonde, R. Gentry, J.W. Moore, T. Bodner
First published December 22, 2003, DOI: https://doi.org/10.1212/01.WNL.0000098878.47789.BD
A.K. Ho
B.J. Sahakian
R.G. Brown
R.A. Barker
J.R. Hodges
M.-N. Ané
J. Snowden
J. Thompson
T. Esmonde
R. Gentry
J.W. Moore
Profile of cognitive progression in early Huntington’s disease
A.K. Ho, B.J. Sahakian, R.G. Brown, R.A. Barker, J.R. Hodges, M.-N. Ané, J. Snowden, J. Thompson, T. Esmonde, R. Gentry, J.W. Moore, T. Bodner
Neurology Dec 2003, 61 (12) 1702-1706; DOI: 10.1212/01.WNL.0000098878.47789.BD
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 61 no. 12 1702-1706
PubMed:
Print ISSN:
Online ISSN:
History:
- Received March 27, 2002
- Accepted August 19, 2003
- First Published December 22, 2003.
Copyright & Usage:
© 2003
Author Disclosures
- A.K. Ho, PhD*,
- B.J. Sahakian, PhD*,
- R.G. Brown, PhD*,
- R.A. Barker, MRCP PhD*,
- J.R. Hodges, MD FRCP*,
- M.-N. Ané, MSc‡,
- J. Snowden, PhD‡,
- J. Thompson, BSc‡,
- T. Esmonde, MD‡,
- R. Gentry, MPhil‡,
- J.W. Moore, D Psychol‡,
- T. Bodner, PhD for‡ and
- for The NEST-HD Consortium§
- A.K. Ho, PhD*,
- B.J. Sahakian, PhD*,
- R.G. Brown, PhD*,
- R.A. Barker, MRCP PhD*,
- J.R. Hodges, MD FRCP*,
- M.-N. Ané, MSc‡,
- J. Snowden, PhD‡,
- J. Thompson, BSc‡,
- T. Esmonde, MD‡,
- R. Gentry, MPhil‡,
- J.W. Moore, D Psychol‡,
- T. Bodner, PhD for‡ and
- for The NEST-HD Consortium§
- From the University of Cambridge (Drs. Ho, Sahakian, and Barker), UK; Institute of Psychiatry (Dr. Brown), London, UK; MRC Cognition and Brain Sciences Unit (Dr. Hodges), Cambridge, UK; Leiden University (M.-N. Ané), the Netherlands; Greater Manchester Neuroscience Centre (Dr. Snowden and J. Thompson), Manchester, UK; Belfast City Hospital (Dr. Esmonde), UK; University of Wales School of Medicine (R. Gentry), Cardiff, UK; Dumfries and Galloway Royal Infirmary (Dr. Moore), Dumfries, UK; and University of Innsbruck (Dr. Bodner), Austria.
- Address correspondence and reprint requests to Dr. Barbara Sahakian, University of Cambridge School of Clinical Medicine, Addenbrooke’s Hospital (Box 189), Cambridge CB2 2QQ UK
Article usage
Cited By...
Letters: Rapid online correspondence
No comments have been published for this article.
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement
Dr. Jeffrey Allen and Dr. Nicholas Purcell
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Article
Clinical manifestations of intermediate allele carriers in Huntington diseaseEsther Cubo, María A. Ramos-Arroyo, Saul Martinez-Horta et al.Neurology, July 08, 2016 -
Null Hypothesis
Clinical manifestations of homozygote allele carriers in Huntington diseaseEsther Cubo, Saul-Indra Martinez-Horta, Frederic Sampedro Santalo et al.Neurology, March 13, 2019 -
Special Article
Evidence-based guideline: Pharmacologic treatment of chorea in Huntington diseaseReport of the Guideline Development Subcommittee of the American Academy of NeurologyMelissa J. Armstrong, Janis M. Miyasaki et al.Neurology, July 18, 2012 -
Articles
Tetrabenazine as antichorea therapy in Huntington diseaseA randomized controlled trialHuntington Study Group et al.Neurology, February 13, 2006